Gupta Vineeta, Kumar Sushil, Sonowal Rimjhim, Singh Surya K
Departments of *Pediatrics †Endocrinology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
J Pediatr Hematol Oncol. 2017 Apr;39(3):214-216. doi: 10.1097/MPH.0000000000000724.
The aim of this study was to evaluate the levels of interleukin (IL)-6 and IL-8 in patients with aplastic anemia and its correlation with severity of the disease.
IL-6 and IL-8 levels were measured in 40 patients with aplastic anemia in the age group of 4 to 14 years. A total of 40 healthy children served as controls. Quantitative estimation of IL-6 and IL-8 was performed using a solid-phase sandwich ELISA kit. Results were presented as IL-6 and IL-8 concentrations in pg/mL. Patients received immunosuppressive therapy per the British Committee for Standards in Haematology Guidelines 2009.
Mean age of the patients was 9.78±2.74 years. IL-6 level of patients was elevated compared with controls (193.48±352.3 vs. 4.58±3.39; P<0.001). IL-8 levels were also significantly elevated in patients compared with controls (15.58±18.0 vs. 1.85±0.95; P<0.001). IL levels were also assessed in relation to severity of the disease. Levels were the highest in patients with very severe aplastic anemia (724.33±519.42), followed by severe aplastic anemia (80.51±66.28 pg/mL), and non-severe aplastic anemia (6.01±1.89). Differences were statistically significant. A similar trend was also observed for IL-8 levels, where the levels were 41.02±24.23, 11.34±8.0, and 1.67±0.71 for very severe aplastic anemia, severe aplastic anemia, and non-severe aplastic anemia, respectively. The differences were again statistically significant. IL levels were also correlated with the treatment outcome. Responders had lower levels compared with nonresponders, but the difference was not statistically significant (186.36±322.45 vs. 198.74±368.10). Levels of ILs decreased in responders, but were not comparable with that of controls 6 months after therapy.
High levels of IL-6 and IL-8 were observed in children with aplastic anemia. Increased levels showed correlation with disease severity and therefore appear to play an important role in aplastic anemia. However, levels had no significant correlation with the treatment outcome.
本研究旨在评估再生障碍性贫血患者白细胞介素(IL)-6和IL-8水平及其与疾病严重程度的相关性。
对40例年龄在4至14岁的再生障碍性贫血患者进行IL-6和IL-8水平检测。选取40名健康儿童作为对照。使用固相夹心酶联免疫吸附测定试剂盒对IL-6和IL-8进行定量评估。结果以pg/mL为单位的IL-6和IL-8浓度表示。患者根据2009年英国血液学标准委员会指南接受免疫抑制治疗。
患者的平均年龄为9.78±2.74岁。与对照组相比,患者的IL-6水平升高(193.48±352.3 vs. 4.58±3.39;P<0.001)。与对照组相比,患者的IL-8水平也显著升高(15.58±18.0 vs. 1.85±0.95;P<0.001)。还根据疾病严重程度评估了IL水平。极重型再生障碍性贫血患者的水平最高(724.33±519.42),其次是重型再生障碍性贫血(80.51±66.28 pg/mL)和非重型再生障碍性贫血(6.01±1.89)。差异具有统计学意义。IL-8水平也观察到类似趋势,极重型再生障碍性贫血、重型再生障碍性贫血和非重型再生障碍性贫血的水平分别为41.02±24.23、11.34±8.0和1.67±0.71。差异同样具有统计学意义。IL水平也与治疗结果相关。与无反应者相比,有反应者的水平较低,但差异无统计学意义(186.36±322.45 vs. 198.74±368.10)。有反应者的IL水平下降,但治疗6个月后与对照组水平不可比。
再生障碍性贫血患儿中观察到高水平的IL-6和IL-8。水平升高与疾病严重程度相关,因此似乎在再生障碍性贫血中起重要作用。然而,水平与治疗结果无显著相关性。